Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study

Keyphrases

• Hazard Ratio 100%
• Adjusted Hazard Ratio 100%
• Clinical Efficacy 100%
• Multicenter Cohort Study 100%
• Left Ventricular Ejection Fraction 100%
• Diabetic 100%
• Primary Prevention 100%
• Dilated Cardiomyopathy 100%
• Ischemic Cardiomyopathy 100%
• ICD Implantation 100%
• 95% Confidence Interval 100%
• Implantable Cardioverter-defibrillator 100%
• Clinical Characteristics 50%
• Mortality Prediction 50%
• Multivariable 50%
• Low Mortality 50%
• European Countries 50%
• All-cause Mortality 50%
• Subgroup Analysis 50%
• Survival Benefit 50%
• Older Patients 50%
• Chronic Obstructive Pulmonary Disease 50%
• Narrow QRS 50%
• Multivariable Model 50%
• 12-lead 50%
• New York Heart Association Class 50%
• Holter Electrocardiogram 50%
• Comparative Effectiveness Research 50%
• Primary Prophylactic ICD 50%
• Cardiomyopathy Dilated 50%
• ICD Therapy 50%
• Model Scoring 50%
• Investigator-initiated 50%
• Follow-up Data 50%
• Propensity Scoring 50%
• Primary Prevention ICD 50%

Medicine and Dentistry

• Cohort Analysis 100%
• Hazard Ratio 100%
• Primary Prevention 100%
• Implantable Cardioverter Defibrillator 100%
• Diabetes Mellitus 50%
• Heart Left Ventricle Ejection Fraction 50%
• Dilated Cardiomyopathy 50%
• Ischemic Cardiomyopathy 50%
• All Cause Mortality 25%
• Subgroup Analysis 25%
• Chronic Obstructive Pulmonary Disease 25%
• Holter Monitoring 25%
• New York Heart Association Class 25%